Timothy C. Crew

Chief Executive Officer

Timothy C. Crew was appointed chief executive officer (CEO) in January 2018.  Mr. Crew most recently served as CEO of Cipla North America, a global pharmaceutical company based in Mumbai, India, from 2013 to 2017.  Previously, he worked for eight years at Teva Pharmaceuticals, where he served as senior vice president and commercial operating officer of the North American Generics division, the world's largest generic operation with multiple billions of dollars of annual sales.  Before that, Mr. Crew was Teva's vice president, Alliances and Business Development.  From 2001 to 2004, Mr. Crew was executive vice president, North America, for Dr. Reddy's Laboratories.  Crew began his pharmaceutical career at Bristol-Myers Squibb, where he held a number of senior management positions in global marketing, managed healthcare, marketing, business development and strategic planning.  Prior to his pharmaceutical roles, Mr. Crew served in the United States Army, where he rose to the rank of Captain.  Mr. Crew earned a Bachelor of Arts degree in economics from Pomona College and a Masters of Business Administration degree from Columbia Business School.

Martin P. Galvan, CPA

Vice President of Finance, Chief Financial Officer and Treasurer

Martin P. Galvan, CPA was appointed as the Company’s Vice President of Finance, Chief Financial Officer and Treasurer in August 2011.  Most recently, he was Chief Financial Officer of CardioNet, Inc., a medical technology and service company.  From 2001 to 2007, Mr. Galvan was employed by Viasys Healthcare Inc., a healthcare technology company that was acquired by Cardinal Health, Inc. in June 2007.  Prior to the acquisition, he served as Executive Vice President, Chief Financial Officer and Director Investor Relations.  From 1999 to 2001, Mr. Galvan served as Chief Financial Officer of Rodel, Inc., a precision surface technologies company in the semiconductor industry.  From 1979 to 1998, Mr. Galvan held several positions with Rhone-Poulenc Rorer Inc., a pharmaceutical company, including Vice President, Finance — The Americas; President & General Manager, RPR Mexico & Central America; Vice President, Finance, Europe/Asia Pacific; and Chief Financial Officer, United Kingdom & Ireland.  Mr. Galvan began his career with the international accounting firm Ernst & Young LLP.  He earned a Bachelor of Arts degree in economics from Rutgers University and is a member of the American Institute of Certified Public Accountants.

Samuel H. Israel

Chief Legal Officer and General Counsel

Samuel H. Israel was appointed vice president, chief legal officer and general counsel in July 2017.  Prior to joining Lannett, Mr. Israel was a partner with Fox Rothschild, a national, full-service law firm, with 22 offices that provide services in more than 60 practice areas.  He served as chair of the firm’s Pharmaceutical and Biotechnology Practice and handled a variety of commercial litigation matters.  Mr. Israel earned a Bachelor of Science degree in chemical engineering from the University of Pennsylvania and a Juris Doctor degree with honors from Rutgers University School of Law.

John Kozlowski

Chief Operating Officer

John Kozlowski joined the Company in 2009 as Corporate Controller and was promoted in 2016 to Vice President Financial Operations & Corporate Controller.  In October 2017, Mr. Kozlowski was promoted to Chief Operating Officer.  Prior to joining the Company, Mr. Kozlowski served in senior finance and accounting roles for Optium Corporation and Finisar Australia.  He earned a Bachelor of Arts degree in finance from James Madison University and a Masters of Business Administration degree from Rider University.

Kevin Smith

Senior Vice President of Sales and Marketing

Kevin R. Smith joined the Company in January 2002 as Vice President of Sales and Marketing.  Prior to this, from 2000 to 2001, he served as Director of National Accounts for Bi-Coastal Pharmaceutical, Inc., a pharmaceutical sales representation company.  Prior to this, from 1999 to 2000, he served as National Accounts Manager for Mova Laboratories Inc., a pharmaceutical manufacturer.  Prior to this, from 1991 to 1999, Mr. Smith served as National Sales Manager at Sidmak Laboratories, a pharmaceutical manufacturer.  Mr. Smith has extensive experience in the generic sales market, and brings to the Company a vast network of customers, including retail chain pharmacies, wholesale distributors, mail-order wholesalers and generic distributors.  Mr. Smith has a Bachelor of Science Degree in Business Administration from Gettysburg College.

John M. Abt

Vice President of Quality

John M. Abt joined the Company as Vice President of Quality, effective March 30, 2015. Prior to joining Lannett, Mr. Abt served as Teva Pharmaceuticals’ Vice President of Global Quality Strategy from 2012 to 2015 where he oversaw the development and implementation of global quality operating plans, standardization and efficiency programs and off shoring efforts. Prior to that he served as the Teva’s Vice President of North America Quality Systems and Compliance from 2009 to 2012 where he was responsible for ensuring compliance of North American production and global supply sites with FDA regulations via the development and execution of effective quality systems. From 2004 to 2009 Mr. Abt was the Vice President of US Operations for Teva overseeing production, engineering, and the integration of acquired facilities among other responsibilities after serving as the Plant Manager of the Teva Sellersville Plant from 2000-2004. Before that, he held a number of quality positions of increasing responsibility at Alpharma from 1988-2000. He earned a Master of Administration Sciences Degree in Management from Johns Hopkins University and his BS in Biochemistry from Niagara University in NY.

Robert Ehlinger

Vice President of Logistics and Chief Information Officer

Robert Ehlinger joined the Company in July 2006 as Chief Information Officer.  In June 2011, Mr. Ehlinger was promoted to Vice President of Logistics and Chief Information Officer.  Prior to joining Lannett, Mr. Ehlinger was the Vice President of Information Technology at MedQuist, Inc., a healthcare services provider, where his career spanned 10 years in progressive operational and technology roles.  Prior to MedQuist, Mr. Ehlinger was with Kennedy Health Systems as their Corporate Director of Information Technology supporting acute care and ambulatory care health information systems and biomedical support services.  Earlier on, Mr. Ehlinger was with Dowty Communications where he held various technical and operational support roles prior to assuming the role of International Distribution Sales Executive managing the Latin America sales distribution channels.  Mr. Ehlinger received a Bachelor’s of Arts degree in Physics from Gettysburg College in Gettysburg, PA.

print email
Lannett Investor Relations
Lannett Company Products